BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Casadei Gardini A, Scarpi E, Orlandi E, Tassinari D, Leo S, Bernardini I, Gelsomino F, Tamberi S, Ruscelli S, Vespignani R, Ronconi S, Frassineti GL, Amadori D, Passardi A. Prognostic role of aspartate aminotransferase-lymphocyte ratio index in patients with metastatic colorectal cancer: results from the randomized ITACa trial. Onco Targets Ther 2018;11:5261-8. [PMID: 30214231 DOI: 10.2147/OTT.S166614] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Young S, Ragulojan R, Todatry S, D’souza D, Golzarian J, Flanagan S, Sanghvi T. Evaluation of Inflammatory Scores in Metastatic Colorectal Cancer Patients Undergoing Transarterial Radioembolization. Cardiovasc Intervent Radiol 2022. [DOI: 10.1007/s00270-022-03313-w] [Reference Citation Analysis]
2 Gemcioglu E, Davutoglu M, Catalbas R, Karabuga B, Kaptan E, Aypak A, Kalem AK, Özdemir M, Yeşilova NY, Kalkan EA, Civak M, Kücüksahin O, Erden A, Ates I. Predictive values of biochemical markers as early indicators for severe COVID-19 cases in admission. Future Virology 2021;16:353-67. [DOI: 10.2217/fvl-2020-0319] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
3 Casadei Gardini A, Scarpi E, Valgiusti M, Monti M, Ruscelli S, Matteucci L, Bartolini G, Vertogen B, Pagan F, Rovesti G, Frassineti GL, Passardi A. Prognostic role of a new index (multi inflammatory index) in patients with metastatic colorectal cancer: results from the randomized ITACa trial. Ther Adv Med Oncol 2020;12:1758835920958363. [PMID: 33062063 DOI: 10.1177/1758835920958363] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
4 Casadei‐gardini A, Cabibbo G, Dadduzio V, Orsi G, Vukotic R, Rizzato MD, Rossi M, Guarneri V, Lonardi S, D'agostino D, Celsa C, Rovesti G, Rimini M, Andreone P, Zagonel V, Scartozzi M, Johnson P, Cascinu S, Cucchetti A. Validation and refinement of PROSASH model using the neutrophil‐to‐lymphocyte ratio in patients with HCC receiving sorafenib. Liver Cancer International 2020;1:6-11. [DOI: 10.1002/lci2.12] [Reference Citation Analysis]
5 Casadei-Gardini A, Scarpi E, Ulivi P, Palladino MA, Accettura C, Bernardini I, Spallanzani A, Gelsomino F, Corbelli J, Marisi G, Ruscelli S, Valgiusti M, Frassineti GL, Passardi A. Prognostic role of a new inflammatory index with neutrophil-to-lymphocyte ratio and lactate dehydrogenase (CII: Colon Inflammatory Index) in patients with metastatic colorectal cancer: results from the randomized Italian Trial in Advanced Colorectal Cancer (ITACa) study. Cancer Manag Res 2019;11:4357-69. [PMID: 31191000 DOI: 10.2147/CMAR.S198651] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
6 Wang Y, Zhao M, Zhao H, Cheng S, Bai R, Song M. MicroRNA-940 restricts the expression of metastasis-associated gene MACC1 and enhances the antitumor effect of Anlotinib on colorectal cancer. Onco Targets Ther 2019;12:2809-22. [PMID: 31114229 DOI: 10.2147/OTT.S195364] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]